Optimizing R/R CLL Treatment: Therapy Sequencing and Supportive Care Strategies - Episode 11
Treatment Sequencing in Relapsed/Refractory CLL: Key Factors Influencing Decision-Making
Panelists discuss how they approach treatment sequencing in relapsed/refractory chronic lymphocytic leukemia (CLL), considering primary factors such as prior therapies, mechanisms of resistance, patient characteristics, and treatment goals to optimize the order and selection of subsequent therapies for improved long-term outcomes.
Video content above is prompted by the following:
- How do you approach treatment sequencing for relapsed/refractory CLL, and what are the primary factors that influence your sequencing decisions?
Related Content:
